Prescription trends show particularly rapid growth for newer agents
Anyone can submit a Yellow Card report for non-trial use, including: Patients and members of the public GPs, pharmacists, nurses, and hospital clinicians Parents or carers reporting on behalf of another person For general queries about medicines safety or to find out more about the Yellow Card Scheme, patients can contact the MHRA directly or speak to their GP or pharmacist
Comprehensive GLP-1 Medication Support This tool features dedicated support for GLP-1 medications, including reminders, dose tracking, symptom logging, and clear progress charts, alongside visualizations of medication levels and patterns across various health metrics
If treatment fails after optimisation, alternatives include SGLT2 inhibitors, insulin therapy, other weight management medications, or bariatric surgery referral